BMYEarnings Release财报快讯Media source媒体来源Source link原始来源August 3, 20262026/8/3by InvestLog AIInvestLog AI 整理

BMY earnings release — EPS beat +27.5% · revenue beat +10.5%百时美施贵宝 (BMY) 财报发布 — EPS 高于预期+27.5% · 营收高于预期+10.5%

Key Results

Bristol-Myers Squibb Company (BMY) published results at 2026-07-30 06:59:00.

EPS: $2.04 vs $1.60 estimate, beat+27.5%.

Revenue: $13.0B vs $11.7B estimate, beat+10.5%.

Period: 2026 Q2 period ended 2026-06-30

Revenue: $13.0B; YoY: +12.9%

Gross profit: $9.2B; Gross margin: 71.3%

Operating income: $4.1B; Operating margin: 31.5%

Net income: $3.3B; GAAP diluted EPS: $1.62

Operating cash flow: $3.4B; Capex: $305M; Free cash flow: $3.1B

Cash: $8.7B; Total debt: $43.1B; Net debt: $34.4B

Official release: Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

百时美施贵宝 (BMY) 已发布财报，发布时间：2026-07-30 06:59:00。

EPS：$2.04 vs $1.60 预期，高于预期+27.5%。

营收：$13.0B vs $11.7B 预期，高于预期+10.5%。

期间：2026 Q2 period ended 2026-06-30

营收：$13.0B；同比：+12.9%

毛利润：$9.2B；毛利率：71.3%

经营利润：$4.1B；经营利润率：31.5%

净利润：$3.3B；GAAP 稀释 EPS：$1.62

经营现金流：$3.4B；资本开支：$305M；自由现金流：$3.1B

现金：$8.7B；总债务：$43.1B；净债务：$34.4B

官方公告：Bristol Myers Squibb Reports Second Quarter Financial Results for 2026

For information only. Not investment advice.内容仅供参考，不构成投资建议。